Research Programs

External and industry-sponsored research program overviews

The Dexcom External Research Program encourages investigators, organizations, and industry to utilize continuous glucose monitoring (CGM) technology as part of their study programs and pursue original diabetes-related research. Typical categories of research that may be eligible for support include:

Investigator-initiated studies (IIS)
Studies sponsored by non-profit groups or other research consortiums (e.g., Artificial Pancreas groups)
Industry-sponsored studies using CGM as a diagnostic or data collection tool (e.g., pharmaceutical research)

Investigator-Initiated Studies (IIS)

Including studies sponsored by non-profit groups or other research consortiums

(e.g., Artificial Pancreas groups)

Submission and Review Process

Electronic submissions should be submitted through the Dexcom External Research web portal (SteepRock). Please allow approximately 8-10 weeks for Dexcom to review and contact you about your initial submission. Details about the program, including submission criteria, review process, and support guidelines, can be found here. For a quick snapshot of the program and the processes, please click here. Electronic submissions should be submitted through the Dexcom External Research web portal. Users must first setup an account from which they will be able to submit and track all projects.

Industry-Sponsored Research

Pharmaceutical integration, Device validation

Phase 1 to Phase 4 research use

As leaders in CGM, the Dexcom Corporate Accounts team works with industry and third party groups to share knowledge, risks, and successes to implement and support Dexcom solutions in their own clinical research programs. Our team has extensive experience to identify the best tools for your needs and work collaboratively to meet requested goals.

To start a discussion about your opportunity, please reach out to us at [email protected].

Requesting Party

Any investigators, organizations, or groups requesting research support from Dexcom will serve as the sponsor of the proposed study.
Requesting parties will be expected to perform the responsibilities of ‘sponsor’ as defined by the United States Code of Federal Regulations (21 CFR, Subpart D) and ICH Guidelines for Good Clinical Practices (GCP) concerning Sponsor Responsibilities, as applicable.
Sponsor responsibilities include, but are not limited to:
- Designing the protocol and conducting the scientific investigation
- Understanding and complying regulatory requirements
- Device tracking and accountability
- Monitoring the study
- Reporting safety data to regulatory authorities, the IRB/EC, and Dexcom, as applicable
- Registering the study on a public web site or any other venue required by law (e.g., www.clinicaltrials.gov), as applicable

Dexcom

May provide limited scientific, technical, data analysis, or training assistance related to Dexcom technology but does not design, conduct, or supervise the study.
Dexcom will perform scientific review of study-related materials before committing to any support, including verification, that research has been submitted to/approved by proper regulatory bodies (e.g., IRB, EC, and FDA, as applicable).
Dexcom may support eligible studies by providing Dexcom products at discounted rates and/or project funding, depending on the scope of the project.

Resources

Dexcom Safety Information: provides approved Indications for Use, Contraindications, Warnings, Precautions, and Cautions for Dexcom products.

Dexcom Product Information: provides links to instructions for use, video tutorials, and others education materials available for Dexcom products.

International: provides information about global availability of Dexcom products.

Contact Information

Research Program Questions

Any questions related to submitting projects to Dexcom’s External Research program can be directed to:
[email protected] - USA

[email protected] - International

Study Orders

Study orders can be submitted to:
[email protected] - USA

[email protected] - International

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider’s NPI

Please provide Facility/Office address Only- We will not ship to home address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.